Antibody Testing Affects MS Therapy Management
In a randomized trial, access to antibody testing affected MS management. Serum binding antibodies predicted positivity to neutralizing antibodies in patients on high-dose interferon.
In a randomized trial, access to antibody testing affected MS management. Serum binding antibodies predicted positivity to neutralizing antibodies in patients on high-dose interferon.
Access to antibody testing affected management in persons with multiple sclerosis, according to findings from...
Clinical Research